ROYAL BANK OF CANADA - ONCOLYTICS BIOTECH INC ownership

ONCOLYTICS BIOTECH INC's ticker is ONCY and the CUSIP is 682310875. A total of 45 filers reported holding ONCOLYTICS BIOTECH INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of ONCOLYTICS BIOTECH INC
ValueSharesWeighting
Q2 2024$62,000
-4.6%
62,267
+2.0%
0.00%
Q1 2024$65,000
-12.2%
61,033
+11.1%
0.00%
Q4 2023$74,000
-38.8%
54,925
-1.4%
0.00%
Q3 2023$121,000
-12.3%
55,729
+4.7%
0.00%
Q2 2023$138,000
+115.6%
53,205
-0.8%
0.00%
Q1 2023$64,000
-15.8%
53,656
+15.6%
0.00%
Q4 2022$76,000
+26.7%
46,434
-4.9%
0.00%
Q3 2022$60,000
+36.4%
48,840
+11.8%
0.00%
Q2 2022$44,000
-38.0%
43,687
-3.0%
0.00%
Q1 2022$71,000
+22.4%
45,046
+8.6%
0.00%
Q4 2021$58,000
-31.8%
41,476
+2.3%
0.00%
Q3 2021$85,000
-16.7%
40,555
+10.6%
0.00%
Q2 2021$102,000
-2.9%
36,652
+33.9%
0.00%
Q1 2021$105,000
+25.0%
27,381
-23.0%
0.00%
Q4 2020$84,000
+61.5%
35,582
+16.2%
0.00%
Q3 2020$52,000
-50.9%
30,619
-45.8%
0.00%
Q2 2020$106,000
+41.3%
56,483
+2.7%
0.00%
Q1 2020$75,000
-73.8%
54,976
-8.6%
0.00%
Q4 2019$286,000
+3985.7%
60,165
+420.7%
0.00%
Q3 2019$7,000
-63.2%
11,555
+2.2%
0.00%
Q2 2019$19,000
-32.1%
11,304
-25.7%
0.00%
Q1 2019$28,000
+100.0%
15,215
+92.8%
0.00%
Q4 2018$14,000
-70.2%
7,891
-35.6%
0.00%
Q3 2018$47,000
-4.1%
12,262
+37.8%
0.00%
Q2 2018$49,0008,8990.00%
Other shareholders
ONCOLYTICS BIOTECH INC shareholders Q4 2023
NameSharesValueWeighting ↓
SEEDS INVESTOR LLC 189,941$188,0420.10%
INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC 198,400$196,4160.02%
BRAVE ASSET MANAGEMENT INC 25,000$24,6670.01%
HEADINVEST, LLC 17,434$17,2600.00%
Ausdal Financial Partners, Inc. 21,000$20,7900.00%
Long Focus Capital Management, LLC 40,000$39,6000.00%
C2P Capital Advisory Group, LLC d.b.a. Prosperity Capital Advisors 15,000$14,8500.00%
Virtu Financial LLC 27,442$270.00%
Activest Wealth Management 5,000$4,9500.00%
PROFESSIONAL ADVISORY SERVICES INC 10,000$100.00%
View complete list of ONCOLYTICS BIOTECH INC shareholders